Back to MLTX
FMR LLC MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
56
Latest value
$5
Q3 2026
Peak value
$256.4M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $6.3M |
| Q2 2022 | $4K |
| Q3 2022 | $6.5M |
| Q3 2022 | $5K |
| Q4 2022 | $1.9M |
| Q1 2023 | $10.2M |
| Q2 2023 | $142.9M |
| Q2 2023 | $26.5M |
| Q2 2023 | $1K |
| Q2 2023 | $2.5M |
| Q2 2023 | $333K |
| Q3 2023 | $159.9M |
| Q3 2023 | $30.5M |
| Q3 2023 | $44K |
| Q3 2023 | $2.8M |
| Q3 2023 | $369K |
| Q4 2023 | $192.9M |
| Q4 2023 | $35.8M |
| Q4 2023 | $141K |
| Q4 2023 | $3M |
| Q4 2023 | $497K |
| Q1 2024 | $168M |
| Q1 2024 | $34.1M |
| Q1 2024 | $161K |
| Q1 2024 | $13.4M |
| Q1 2024 | $3.9M |
| Q2 2024 | $116.5M |
| Q2 2024 | $22.2M |
| Q2 2024 | $109K |
| Q2 2024 | $16.9M |
| Q2 2024 | $4.5M |
| Q3 2024 | $191.2M |
| Q3 2024 | $25.6M |
| Q3 2024 | $110K |
| Q3 2024 | $19.2M |
| Q3 2024 | $13.5M |
| Q4 2024 | $256.4M |
| Q4 2024 | $40.5M |
| Q4 2024 | $41K |
| Q4 2024 | $23.1M |
| Q4 2024 | $23.3M |
| Q1 2025 | $182.6M |
| Q1 2025 | $29.3M |
| Q1 2025 | $5K |
| Q1 2025 | $16.1M |
| Q1 2025 | $19.2M |
| Q3 2025 | $5.2M |
| Q3 2025 | $15K |
| Q3 2025 | $925 |
| Q4 2025 | $2.1M |
| Q4 2025 | $434 |
| Q1 2026 | $2.7M |
| Q1 2026 | $15 |
| Q2 2026 | $2.8M |
| Q2 2026 | $16 |
| Q3 2026 | $5 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5 | 0 | — | — |
| Q2 2026 | $16 | 1 | — | — |
| Q2 2026 | $2.8M | 143.6K | — | — |
| Q1 2026 | $15 | 1 | — | — |
| Q1 2026 | $2.7M | 143.6K | — | — |
| Q4 2025 | $434 | 33 | — | — |
| Q4 2025 | $2.1M | 156.2K | — | — |
| Q3 2025 | $925 | 129 | — | — |
| Q3 2025 | $15K | 2.1K | — | — |
| Q3 2025 | $5.2M | 724.7K | — | — |
| Q1 2025 | $19.2M | 490.2K | — | — |
| Q1 2025 | $16.1M | 411.3K | — | — |
| Q1 2025 | $5K | 135 | — | — |
| Q1 2025 | $29.3M | 751.2K | — | — |
| Q1 2025 | $182.6M | 4.67M | — | — |
| Q4 2024 | $23.3M | 429.8K | — | — |
| Q4 2024 | $23.1M | 426.7K | — | — |
| Q4 2024 | $41K | 762 | — | — |
| Q4 2024 | $40.5M | 748.5K | — | — |
| Q4 2024 | $256.4M | 4.74M | — | — |
| Q3 2024 | $13.5M | 268.0K | — | — |
| Q3 2024 | $19.2M | 379.9K | — | — |
| Q3 2024 | $110K | 2.2K | — | — |
| Q3 2024 | $25.6M | 508.7K | — | — |
| Q3 2024 | $191.2M | 3.79M | — | — |
| Q2 2024 | $4.5M | 101.9K | — | — |
| Q2 2024 | $16.9M | 384.6K | — | — |
| Q2 2024 | $109K | 2.5K | — | — |
| Q2 2024 | $22.2M | 504.7K | — | — |
| Q2 2024 | $116.5M | 2.65M | — | — |
| Q1 2024 | $3.9M | 78.3K | — | — |
| Q1 2024 | $13.4M | 266.1K | — | — |
| Q1 2024 | $161K | 3.2K | — | — |
| Q1 2024 | $34.1M | 678.8K | — | — |
| Q1 2024 | $168M | 3.34M | — | — |
| Q4 2023 | $497K | 8.2K | — | — |
| Q4 2023 | $3M | 49.7K | — | — |
| Q4 2023 | $141K | 2.3K | — | — |
| Q4 2023 | $35.8M | 593.0K | — | — |
| Q4 2023 | $192.9M | 3.19M | — | — |
| Q3 2023 | $369K | 6.5K | — | — |
| Q3 2023 | $2.8M | 49.7K | — | — |
| Q3 2023 | $44K | 771 | — | — |
| Q3 2023 | $30.5M | 535.9K | — | — |
| Q3 2023 | $159.9M | 2.80M | — | — |
| Q2 2023 | $333K | 6.5K | — | — |
| Q2 2023 | $2.5M | 49.7K | — | — |
| Q2 2023 | $1K | 22 | — | — |
| Q2 2023 | $26.5M | 519.7K | — | — |
| Q2 2023 | $142.9M | 2.80M | — | — |
| Q1 2023 | $10.2M | 475.4K | — | — |
| Q4 2022 | $1.9M | 185.5K | — | — |
| Q3 2022 | $5K | 596 | — | — |
| Q3 2022 | $6.5M | 818.6K | — | — |
| Q2 2022 | $4K | 849 | — | — |
| Q2 2022 | $6.3M | 1.19M | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$187.2M
$136.3M
$120.8M
$119.5M
$118.4M